Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Future Oncology (London, England)|February 2, 2022
Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experienceCharles Dharmani, Eric Wang, Maribel Salas, et al.Canadian Liver Journal|July 18, 2025
The effect of spatial variation on linkage to care and treatment rates among patients with hepatitis C: A Canadian population-based studyShubhreet Gill, Rizwan Shahid, Ranjani Somayaji, et al.Biomolecules|January 23, 2024
The 2.6 Å Structure of a Tulane Virus Variant with Minor Mutations Leading to Receptor ChangeChen Sun, Pengwei Huang, Xueyong Xu, et al.Royal Society Open Science|October 2, 2025
An analysis of silk density in spider websFangyuan Lin, Kathryn Michelle Nagel, Seewoo Lee, et al.Journal of the American Chemical Society|September 9, 2025
Biosynthesis of Unnatural Cyclodipeptides through Genetic Code Expansion and Cyclodipeptide Synthase EvolutionYu Hu, Linqi Cheng, Yijie Liu, et al.Investigative Ophthalmology & Visual Science|August 29, 2007
Coated microneedles for drug delivery to the eyeJason Jiang, Harvinder S Gill, Deepta Ghate, et al.Drug Safety|October 24, 2023
Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World UseLoreta Marquez, Ritu Raheja, May Chan-Liston, et al.The Oncologist|February 12, 2015
Phase I dose-escalation study of pilaralisib (SAR245408, XL147), a pan-class I PI3K inhibitor, in combination with erlotinib in patients with solid tumorsJean-Charles Soria, Patricia LoRusso, Ratislav Bahleda, et al.BMC Health Services Research|February 16, 2024
Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver diseaseSeungwon Lee, Abdel Aziz Shaheen, David J T Campbell, et al.Cell Reports|September 24, 2025
Functional consequences of reductive protein evolution in a minimal eukaryotic genomeJason Jiang, Rui Qu, Maria Grigorescu, et al.Pageof 4